Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Ames

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Investigational New Drugs|August 1, 1991
Differences in N-acetylation of the experimental antitumor agent batracylin in the mouse and the ratM M Ames, D A Mathiesen, J M Reid
Journal of Surgical Oncology|September 1, 1983
In vitro chemotherapy sensitivity patterns of human colon carcinoma continuous cell linesM V Agrez, M M Ames, M M Lieber
Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 2001
Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamideS L Safgren, J M Reid, R Rios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancerJ M Reid, D C Stevens, J Rubin, et al.
Cancer Research|December 1, 1979
Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humansM M Ames, G Powis, J S Kovach, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Preclinical pharmacology of cholera toxinJ M Reid, J W Benson, J Viallet, et al.
Cancer Treatment Reports|February 1, 1982
Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitolR T Eagan, M M Ames, G Powis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
The Hsp90 chaperone complex as a novel target for cancer therapyM P Goetz, D O Toft, M M Ames, et al.
Investigational New Drugs|January 1, 1995
Phase I trial of diaziquone (AZQ) plus GM-CSFL C Hartmann, M M Ames, J M Reid, et al.
Cancer Investigation|January 1, 1990
Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicityC L Loprinzi, R R Love, J A Garrity, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Investigational New Drugs|August 1, 1991
Differences in N-acetylation of the experimental antitumor agent batracylin in the mouse and the ratM M Ames, D A Mathiesen, J M Reid
Journal of Surgical Oncology|September 1, 1983
In vitro chemotherapy sensitivity patterns of human colon carcinoma continuous cell linesM V Agrez, M M Ames, M M Lieber
Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 2001
Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamideS L Safgren, J M Reid, R Rios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancerJ M Reid, D C Stevens, J Rubin, et al.
Cancer Research|December 1, 1979
Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humansM M Ames, G Powis, J S Kovach, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Preclinical pharmacology of cholera toxinJ M Reid, J W Benson, J Viallet, et al.
Cancer Treatment Reports|February 1, 1982
Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitolR T Eagan, M M Ames, G Powis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
The Hsp90 chaperone complex as a novel target for cancer therapyM P Goetz, D O Toft, M M Ames, et al.
Investigational New Drugs|January 1, 1995
Phase I trial of diaziquone (AZQ) plus GM-CSFL C Hartmann, M M Ames, J M Reid, et al.
Cancer Investigation|January 1, 1990
Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicityC L Loprinzi, R R Love, J A Garrity, et al.
Pageof 9